Regulation of cerebrospinal fluid production by caffeine consumption

被引:51
作者
Han, Myoung-Eun [1 ,2 ]
Kim, Hak-Jin [3 ]
Lee, Young-Suk [1 ]
Kim, Dong-Hyun [4 ]
Choi, Joo-Taek [1 ]
Pan, Chul-Sik [1 ]
Yoon, Sik [1 ,2 ]
Baek, Sun-Yong [1 ]
Kim, Bong-Seon [1 ]
Kim, Jae-Bong [1 ]
Oh, Sae-Ock [1 ,2 ]
机构
[1] Pusan Natl Univ, Sch Med, Dept Anat, Pusan, South Korea
[2] Pusan Natl Univ, Med Res Ctr Ischem Tissue Regenerat, Pusan, South Korea
[3] Pusan Natl Univ, Sch Med, Dept Radiol, Pusan, South Korea
[4] Pusan Natl Univ, Sch Med, Dept Biomed Engn, Pusan, South Korea
来源
BMC NEUROSCIENCE | 2009年 / 10卷
关键词
ADENOSINE A(2A) RECEPTOR; LONG-TERM CAFFEINE; GERBIL HIPPOCAMPUS; RAT-BRAIN; MICE; A(1); SEIZURES; HYPOXIA; BINDING; SUSCEPTIBILITY;
D O I
10.1186/1471-2202-10-110
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Caffeine is the most commonly consumed psycho-stimulant in the world. The effects of caffeine on the body have been extensively studied; however, its effect on the structure of the brain has not been investigated to date. Results: In the present study we found that the long-term consumption of caffeine can induce ventriculomegaly; this was observed in 40% of the study rats. In the caffeine-treated rats with ventriculomegaly, there was increased production of CSF, associated with the increased expression of Na+, K+-ATPase and increased cerebral blood flow (CBF). In contrast to the chronic effects, acute treatment with caffeine decreased the production of CSF, suggesting 'effect inversion' associated with caffeine, which was mediated by increased expression of the A(1) adenosine receptor, in the choroid plexus of rats chronically treated with caffeine. The involvement of the A(1) adenosine receptor in the effect inversion of caffeine was further supported by the induction of ventriculomegaly and Na+, K+-ATPase, in A(1) agonist-treated rats. Conclusion: The results of this study show that long-term consumption of caffeine can induce ventriculomegaly, which is mediated in part by increased production of CSF. Moreover, we also showed that adenosine receptor signaling can regulate the production of CSF by controlling the expression of Na+, K+-ATPase and CBF.
引用
收藏
页数:12
相关论文
共 45 条
[1]   Moderate cerebral venous congestion induces rapid cerebral protection via adenosine A1 receptor activation [J].
Akaiwa, Keiichi ;
Akashi, Hidetoshi ;
Harada, Hideki ;
Sakashita, Hideki ;
Hiromatsu, Shinichi ;
Kano, Tatsuhiko ;
Aoyai, Shigeaki .
BRAIN RESEARCH, 2006, 1122 :47-55
[2]   CAFFEINE MODIFICATION OF KINDLED AMYGDALOID SEIZURES [J].
ALBERTSON, TE ;
JOY, RM ;
STARK, LG .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 19 (02) :339-343
[3]   Effects of caffeine on learning and memory in rats tested in the Morris water maze [J].
Angelucci, MEM ;
Cesário, C ;
Hiroi, RH ;
Rosalen, PL ;
Da Cunha, C .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2002, 35 (10) :1201-1208
[4]   PRO-CONVULSANT ACTIONS OF THEOPHYLLINE AND CAFFEINE IN THE HIPPOCAMPUS - IMPLICATIONS FOR THE MANAGEMENT OF TEMPORAL-LOBE EPILEPSY [J].
AULT, B ;
OLNEY, MA ;
JOYNER, JL ;
BOYER, CE ;
NOTRICA, MA ;
SOROKO, FE ;
WANG, CM .
BRAIN RESEARCH, 1987, 426 (01) :93-102
[5]   Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury [J].
Back, Stephen A. ;
Craig, Andrew ;
Luo, Ning Ling ;
Ren, Jennifer ;
Akundi, Ravi Shankar ;
Ribeiro, Ivy ;
Rivkees, Scott A. .
ANNALS OF NEUROLOGY, 2006, 60 (06) :696-705
[6]   Caffeine consumption [J].
Barone, JJ ;
Roberts, HR .
FOOD AND CHEMICAL TOXICOLOGY, 1996, 34 (01) :119-129
[7]  
BAYNE K, 1996, PHYSIOLOGIST, V39
[8]   Vasopressin mediates the inhibitory effect of central angiotensin II on cerebrospinal fluid formation [J].
Chodobski, A ;
Szmydynger-Chodobska, J ;
Johanson, CE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 347 (2-3) :205-209
[9]   Caffeine alters plasma adenosine levels [J].
Conlay, LA ;
Conant, JA ;
deBros, F ;
Wurtman, R .
NATURE, 1997, 389 (6647) :136-136
[10]   Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade [J].
El Yacoubi, M ;
Ledent, C ;
Parmentier, M ;
Costentin, J ;
Vaugeois, JM .
NEUROPHARMACOLOGY, 2003, 45 (07) :977-985